In this study we provide the first evidence that systemic in vivo targeting of eEF-2K expression by liposomal siRNA inhibits growth (Figure 3B) and induces apoptosis (Figure 3D and 3E) of established tumors in an orthotopic xenograft model of a highly aggressive and metastatic breast cancer. Here, EEF2K is linked to breast carcinoma.